Treatment of Cervical Cancer.
10.5124/jkma.2007.50.9.785
- Author:
Soon Beom KANG
1
Author Information
1. Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Korea. ksboo308@plaza.snu.ac.kr
- Publication Type:Original Article
- Keywords:
Cervical cancer;
Radical hysterectomy;
Chemoradiation
- MeSH:
Drug Therapy;
Lymph Nodes;
Neoplasm Metastasis;
Quality of Life;
Risk Factors;
Uterine Cervical Neoplasms*
- From:Journal of the Korean Medical Association
2007;50(9):785-795
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The treatment modality of cervical cancer depends on the stage and tumor size. In nonadvanced, non-bulky cervical cancers, both surgery and chemoradiation are equally effective. Therefore, the treatment modality is chosen based on the complication rate and the quality of life after treatment. When risk factors such as the positive resection margin, lymph node metastasis, parametrial invasion, bulky disease over 4cm, deep stromal invasion, and lymphovascular space involvement are present after surgery, adjuvant chemoradiation should be performed. In non-advanced, bulky cervical cancers, the optimal treatment is controversial. As a primary therapy, chemoradiation, neoadjuvant chemotherapy and radical surgery, or radical surgery is used. In advanced cervical cancers, chemoradiation is the treatment of choice. However, the indication of paraaortic radiation is still controversial.
